SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-068165
Filing Date
2023-06-05
Accepted
2023-06-05 17:54:10
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2317841-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2317841-2_4seq1.xml 4 4076
  Complete submission text file 0001104659-23-068165.txt   5491
Mailing Address C/O MIRNA THERAPEUTICS, INC. 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address
Winkler Matthew (Reporting) CIK: 0001652067 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40344 | Film No.: 23994136

Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Issuer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments